ORIGINAL RESEARCH article

Front. Mol. Biosci., 04 July 2022

Sec. Molecular Diagnostics and Therapeutics

Volume 9 - 2022 | https://doi.org/10.3389/fmolb.2022.860525

RETRACTED: Identification of a Novel Ferroptosis Inducer for Gastric Cancer Treatment Using Drug Repurposing Strategy

Retracted

A retraction of this article was approved in:

  1. Retraction: Identification of a novel ferroptosis inducer for gastric cancer treatment using drug repurposing strategy

    1. Read retraction
Jinping ZhangJinping Zhang1Meimei GaoMeimei Gao2Ying NiuYing Niu1Jiangang Sun Jiangang Sun3*
  • 1Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  • 2Henan Key Laboratory of Precision Clinical Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  • 3Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Zhang J, Gao M, Niu Y and Sun J (2022) Identification of a Novel Ferroptosis Inducer for Gastric Cancer Treatment Using Drug Repurposing Strategy. Front. Mol. Biosci. 9:860525. doi: 10.3389/fmolb.2022.860525

Received: 23 January 2022; Accepted: 07 June 2022;
Published: 04 July 2022; Retracted: 11 September 2024.

Edited by:

Gilbert O. Fruhwirth, King’s College London, United Kingdom

Reviewed by:

Hironobu Yasui, Hokkaido University, Japan
Flavia Biamonte, Magna Græcia University of Catanzaro, Italy
Weiguang Sun, Huazhong University of Science and Technology, China
Zhimei Li, Northwestern Polytechnical University, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.